We are live on ! Find out more
IMGN

Immunogen Inc
IMGN

Delisted

IMGN was delisted on the 9th of February, 2024.

Back to rankings

131 hedge funds and large institutions have $423M invested in Immunogen Inc in 2014 Q4 according to their latest regulatory filings, with 21 funds opening new positions, 50 increasing their positions, 37 reducing their positions, and 30 closing their positions.

New
Increased
Maintained
Reduced
Closed

179% more call options, than puts

Call options by funds: $11.2M | Put options by funds: $4.03M

35% more repeat investments, than reductions

Existing positions increased: 50 | Existing positions reduced: 37

7% less funds holding

Funds holding: 141 → 131 (-10)

30% less first-time investments, than exits

New positions opened: 21 | Existing positions closed: 30

47% less capital invested

Capital invested by funds: $795M → $423M (-$372M)

100% less funds holding in top 10

Funds holding in top 10: 1 → 0 (-1)

Holders
131
Holders Change
-10
Holders Change %
-7.09%
% of All Funds
3.49%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
21
Increased
50
Reduced
37
Closed
30
Calls
$11.2M
Puts
$4.03M
Net Calls
+$7.2M
Net Calls Change
+$2.39M

Top Buyers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
+$12.3M
2
BIM
Bogle Investment Management
Massachusetts
+$7.06M
3
Norges Bank
Norges Bank
Norway
+$5.87M
4
D.E. Shaw & Co
D.E. Shaw & Co
New York
+$5.72M
5
ClearBridge Investments
ClearBridge Investments
New York
+$4.28M

Top Sellers

Rank Fund Capital Flow
1
First Trust Advisors
First Trust Advisors
Illinois
-$61.5M
2
SAM
Sectoral Asset Management
Quebec, Canada
-$24M
3
AG
Artal Group
Luxembourg
-$13.7M
4
Invesco
Invesco
Georgia
-$9.86M
5
Fidelity Investments
Fidelity Investments
Massachusetts
-$7.71M
Name Holding Trade Value Shares
Change 		Change in
Stake
TCIM
26
TIAA CREF Investment Management
New York
$1.86M -$271K -29,620 -9%
GC
27
Guggenheim Capital
Illinois
$1.84M +$511K +55,875 +23%
Macquarie Group
28
Macquarie Group
Australia
$1.77M – – –
Charles Schwab
29
Charles Schwab
California
$1.6M +$304K +33,190 +15%
MIG
30
Mariner Investment Group
New York
$1.57M +$937K +102,500 +66%
ARTA
31
A.R.T. Advisors
New York
$1.48M +$2.22M +242,432 New
BIM
32
BlackRock Investment Management
Delaware
$1.43M -$17.7K -1,931 -0.8%
Goldman Sachs
33
Goldman Sachs
New York
$1.38M +$68.5K +7,493 +3%
Citadel Advisors
34
Citadel Advisors
Florida
$1.14M +$532K +58,148 +45%
CS
35
Credit Suisse
Switzerland
$1.14M +$1.18M +128,632 +224%
JG
36
Jefferies Group
New York
$1.06M +$1.59M +173,341 New
AllianceBernstein
37
AllianceBernstein
Tennessee
$1M -$24.7K -2,706 -2%
Barclays
38
Barclays
United Kingdom
$997K +$193K +21,067 +15%
Renaissance Technologies
39
Renaissance Technologies
New York
$993K -$1.9M -207,606 -56%
California State Teachers Retirement System (CalSTRS)
40
California State Teachers Retirement System (CalSTRS)
California
$971K +$6.19K +677 +0.4%
BTS
41
BB&T Securities
Virginia
$956K +$45.1K +4,927 +46%
California Public Employees Retirement System
42
California Public Employees Retirement System
California
$874K -$86.9K -9,500 -7%
TFCP
43
Twin Focus Capital Partners
Massachusetts
$855K -$3.46K -378 -0.3%
TA
44
Teachers Advisors
New York
$744K – – –
SIM
45
Spark Investment Management
New York
$710K +$1.07M +116,500 New
USAA
46
United Services Automobile Association
Texas
$696K – – –
LK
47
Lumbard & Kellner
New Hampshire
$669K +$118K +12,935 +13%
Citigroup
48
Citigroup
New York
$608K +$312K +34,066 +52%
SGAM
49
Smith Group Asset Management
Texas
$597K -$86.1K -9,410 -9%
Swiss National Bank
50
Swiss National Bank
Switzerland
$587K +$18.3K +2,000 +2%
1
2
3 4 5

IMGN Hedge Fund Activity: Q4 2014 in Review

131 of the 3,749 institutional investors tracked by Wall St. Rank reported a position in Immunogen Inc (IMGN) for Q4 2014, worth a combined $423M — down 47% from $795M a quarter earlier.

Sellers outnumbered buyers: 30 funds closed out of IMGN and 21 opened new positions — a net loss of 9 holders — while 37 trimmed existing stakes and 50 added.

The largest buyer was Millennium Management, adding an estimated $12.3M. The largest seller was First Trust Advisors, exiting entirely with an estimated $61.5M sold.

  • 131 institutional investors held Immunogen Inc (IMGN) as of Q4 2014, down from 141 in Q3 2014.
  • Funds reported $423M of Immunogen Inc stock for Q4 2014, down 47% quarter-over-quarter.
  • 21 funds opened new Immunogen Inc positions in Q4 2014 and 30 closed out, a net change of -9 holders.
  • The largest Immunogen Inc buyer in Q4 2014 was Millennium Management, an estimated $12.3M added.
  • The largest Immunogen Inc seller in Q4 2014 was First Trust Advisors, an estimated $61.5M sold.

Based on aggregated 13F filings for Q4 2014.